GENIE 17.0-Public Release

<

>

Featured Cancer

March is kidney cancer awareness month. Kidney cancer is the 7th most common cancer diagnosed
in the United States with more than new 81,000 cases each year.
The #AACRGENIE 17.0 public release provides a detailed look at the genomic landscape of Kidney
Cancer, offering valuable insights. The registry includes 3,174 patients and 3,379 samples, helping to
deepen our understanding of this cancer. VHL, PBRM1, SETD2, and BAP1 are the most frequently
mutated genes among other key mutations.
AACRGENIE, celebrating a decade of collaboration and powering the future of precision oncology.
Explore the data on cBioPortal.

The LATEST

• The latest GENIE publication: Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC) – ScienceDirect, Elsevier, Volume 7, March 2025.
• A snapshot of a year of progress: 2024_Year_in_Review.
• Watch the latest Believe in Progress episode: AACR Project GENIE: A Conversation with Shawn M. Sweeney, PhD, and Philippe L. Bedard, MD.
• New public data portal available from Sage Bionetworks.
• The BioPharma Collaborative’s CRC v2.0-Public and NSCLC 2.0-Public datasets are now available.
• Learn more about AACR Project GENIE data included as part of sotorasib regulatory approval.

Visit AACR PROJECT GENIE® BLOG for further information.